The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
Recent developments in nitric oxide donor drugs
Open accessAbstract
During the 1980s, the free radical, nitric oxide (NO), was discovered to be a crucial signalling molecule, with wide‐ranging functions in the cardiovascular, nervous and immune systems. Aside from providing a credible explanation for the actions of organic nitrates and sodium nitroprusside that have long been used in the treatment of angina and hypertensive crises respectively, the discovery generated great hopes for new NO‐based treatments for a wide variety of ailments. Decades later, however, we are still awaiting novel licensed agents in this arena, despite an enormous research effort to this end. This review explores some of the most promising recent advances in NO donor drug development and addresses the challenges associated with NO as a therapeutic agent. British Journal of Pharmacology(2007)151, 305–321; doi:10.1038/sj.bjp.0707224
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
Ludmer, P. L., Selwyn, A. P., Shook, T. L., Wayne, R. R., Mudge, G. H., Alexander, R. W., & Ganz, P. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610233151702 · Cited by 2,425
GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,118
A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans
Liu, L., Hausladen, A., Zeng, M., Que, L., Heitman, J., & Stamler, J. S. (2001) · Nature · doi:10.1038/35068596 · Cited by 913 · cited 2×
“…from S-nitrosothiols, including light, heat, transition metals, thiols, superoxide and enzymes such as xanthine oxidase (Trujillo et al., 1998), superoxide dismutase (Jourd’heuil et al., 1999), protein disulphide isomerase (Ramachandran et al., 2001) and various dehydrogenases (Liu et al., 2001).”
BackgroundCoxibs and Cardiovascular Disease
FitzGerald, G. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048288 · Cited by 899
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818 · cited 2×
“…dysfunction, occurring at a number of levels, including downregulation of eNOS expression and activity, uncoupling of NOS, scavenging of NO by oxygen-centred free radicals and decreased sensitivity of VSMCs to vasodilators, together with NO-independent alterations (Feletou and Vanhoutte, 2006).”
BackgroundDimmeler, S., Haendeler, J., Nehls, M., & Zeiher, A. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.601 · Cited by 806
Culotta, E., & Koshland, D. E. (1992) · Science · doi:10.1126/science.1361684 · Cited by 786
Maragos, C. M., Morley, D., Wink, D. A., Dunams, T. M., Saavedra, J. E., Hoffman, A., Bove, A. A., Isaac, L., Hrabie, J. A., & Keefer, L. K. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00115a013 · Cited by 722
Münzel, T., Sayegh, H., Freeman, B. A., Tarpey, M. M., & Harrison, D. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117637 · Cited by 655
New nitric oxide-releasing zwitterions derived from polyamines
Hrabie, J. A., Klose, J. R., Wink, D. A., & Keefer, L. K. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00058a030 · Cited by 592
Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Identification of the enzymatic mechanism of nitroglycerin bioactivation
Chen, Z., Zhang, J., & Stamler, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122225199 · Cited by 541
Calver, A., Collier, J., & Vallance, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116149 · Cited by 522
(2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00678-5 · Cited by 501
The Chemistry of S-Nitrosothiols
Williams, D. L. H. (1999) · Accounts of Chemical Research · doi:10.1021/ar9800439 · Cited by 497
Ignarro, L. J., Napoli, C., & Loscalzo, J. (2002) · Circulation Research · doi:10.1161/hh0102.102330 · Cited by 491
Singel, D. J., & Stamler, J. S. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.060603.090918 · Cited by 481
Nitric oxide generation from nitroprusside by vascular tissue
Bates, J. N., Baker, M. T., Guerra, R., & Harrison, D. G. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90406-u · Cited by 461
Hallas, J., Dall, M., Andries, A., Andersen, B. S., Aalykke, C., Hansen, J. M., Andersen, M., & Lassen, A. T. (2006) · BMJ · doi:10.1136/bmj.38947.697558.ae · Cited by 403
Bryan, N. S., Rassaf, T., Maloney, R. E., Rodriguez, C. M., Saijo, F., Rodriguez, J. R., & Feelisch, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306706101 · Cited by 400
Inhaled Nitric Oxide Therapy in Adults
Griffiths, M. J. D., & Evans, T. W. (2005) · New England Journal of Medicine · doi:10.1056/nejmra051884 · Cited by 398
Katz, S. D., Biasucci, L., Sabba, C., Strom, J. A., Jondeau, G., Galvao, M., Solomon, S., Nikolic, S. D., Forman, R., & LeJemtel, T. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90271-n · Cited by 394
Beltrán, B., Mathur, A., Duchen, M. R., Erusalimsky, J. D., & Moncada, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14602 · Cited by 393
Yusuf, S., Macmahon, S., Collins, R., & Peto, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91906-x · Cited by 392
Biological significance of nitric oxide-mediated protein modifications
Gow, A. J., Farkouh, C. R., Munson, D. A., Posencheg, M. A., & Ischiropoulos, H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2003 · Cited by 385
Newby, D. E., Wright, R. A., Labinjoh, C., Ludlam, C. A., Fox, K. A. A., Boon, N. A., & Webb, D. J. (1999) · Circulation · doi:10.1161/01.cir.99.11.1411 · Cited by 382
Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols
Brown, G. C., & Borutaite, V. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.03.016 · Cited by 344 · cited 1×
“Of particular note is the inhibitory impact of NO, together with endogenous S-nitrosothiols and ONOO on cellular respiration through interaction with complexes in the respiratory chain (Beltran et al., 2000; Brown and Borutaite, 2004).”
BackgroundFrost, M. C., Reynolds, M. M., & Meyerhoff, M. E. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.006 · Cited by 343
Non-Heme Iron Nitrosyls in Biology
Butler, A. R., & Megson, I. L. (2002) · Chemical Reviews · doi:10.1021/cr000076d · Cited by 343
Self-citationJantzen, P. T., Connor, K. E., DiCarlo, G., Wenk, G. L., Wallace, J. L., Rojiani, A. M., Coppola, D., Morgan, D., & Gordon, M. N. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02246.2002 · Cited by 340
Calver, A., Collier, J., Moncada, S., & Vallance, P. J. (1992) · PubMed · Cited by 332
Gladwin, M. T., Raat, N. J. H., Shiva, S., Dezfulian, C., Hogg, N., Kim-Shapiro, D. B., & Patel, R. P. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00407.2006 · Cited by 329
Sydow, K., Daiber, A., Oelze, M., Chen, Z., August, M., Wendt, M., Ullrich, V., Mülsch, A., Schulz, E., Keaney, J. F., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419267 · Cited by 300
Nitric oxide and the proliferation of vascular smooth muscle cells
Jeremy, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00171-6 · Cited by 285
WINBURY, M. M., HOWE, B. B., & HEFNER, M. A. (1969) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28302-1 · Cited by 277
Saavedra, J. E., Billiar, T. R., Williams, D. L., Kim, Y.-M., Watkins, S. C., & Keefer, L. K. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9701031 · Cited by 273
Calver, A., Collier, J., Moncada, S., & Vallance, P. (1992) · Journal of Hypertension · doi:10.1097/00004872-199209000-00017 · Cited by 240
NO-Releasing Zeolites and Their Antithrombotic Properties
Wheatley, P. S., Butler, A. R., Crane, M. S., Fox, S., Xiao, B., Rossi, A. G., Megson, I. L., & Morris, R. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0503579 · Cited by 235
Self-citationZai, A., Rudd, M. A., Scribner, A. W., & Loscalzo, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4890 · Cited by 234
Münzel, T., Li, H., Mollnau, H., Hink, U., Matheis, E., Hartmann, M., Oelze, M., Skatchkov, M., Warnholtz, A., Duncker, L., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.1.e7 · Cited by 234
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation
Chen, Z., Foster, M. W., Zhang, J., Mao, L., Rockman, H. A., Kawamoto, T., Kitagawa, K., Nakayama, K. I., Hess, D. T., & Stamler, J. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503723102 · Cited by 231
Marks, D. S., Vita, J. A., Folts, J. D., Keaney, J. F., Welch, G. N., & Loscalzo, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118328 · Cited by 230
Fiorucci, S., Santucci, L., Gresele, P., Faccino, R. M., del Soldato, P., & Morelli, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50096 · Cited by 224
Mooradian, D. L., Hutsell, T. C., & Keefer, L. K. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199504000-00023 · Cited by 221
Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population
García Rodríguez, L. A., Varas-Lorenzo, C., Maguire, A., & González-Pérez, A. (2004) · Circulation · doi:10.1161/01.cir.0000132491.96623.04 · Cited by 221
Mowery, K. A., H. Schoenfisch, M., Saavedra, J. E., Keefer, L. K., & Meyerhoff, M. E. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00127-1 · Cited by 219
Napoli, C., & Ignarro, L. J. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140226 · Cited by 216
S-Nitrosothiols: a class of nitric oxide-donor drugs
AL-SA'DONI, H., & FERRO, A. (2000) · Clinical Science · doi:10.1042/cs0980507 · Cited by 204
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty
Langford, E., Brown, A. S., de Belder, A., Smith, R. E. A., Martin, J. F., Wainwright, R. J., Thomas, M. R., Radomski, M. W., & Moncada, S. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90287-9 · Cited by 202
Yamamoto, T., & Bing, R. J. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22525.x · Cited by 193
Xanthine Oxidase-mediated Decomposition of S-Nitrosothiols
Trujillo, M., Alvarez, M. N., Peluffo, G., Freeman, B. A., & Radi, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.7828 · Cited by 192
Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells
Brown, J. F., Keates, A. C., Hanson, P. J., & Whittle, B. J. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.265.3.g418 · Cited by 191
Masters, K. S. B., Leibovich, S. J., Belem, P., West, J. L., & Poole‐Warren, L. A. (2002) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2002.10503.x · Cited by 189
Keeble, J. E., & Moore, P. K. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704876 · Cited by 187
Stamler, J. S., Simon, D. I., Jaraki, O., Osborne, J. A., Francis, S., Mullins, M., Singel, D., & Loscalzo, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8087 · Cited by 185
Nitric oxide enhances experimental wound healing in diabetes
Witte, M. B., Kiyama, T., & Barbul, A. (2002) · British Journal of Surgery · doi:10.1046/j.1365-2168.2002.02263.x · Cited by 181
Ramachandran, N., Root, P., Jiang, X.-M., Hogg, P. J., & Mutus, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171180998 · Cited by 179
Daiber, A., Oelze, M., Coldewey, M., Bachschmid, M., Wenzel, P., Sydow, K., Wendt, M., Kleschyov, A. L., Stalleicken, D., Ullrich, V., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002600 · Cited by 177
Nitrates and no release: contemporary aspects in biological and medicinal chemistry
Thatcher, G. R. J., Nicolescu, A. C., Bennett, B. M., & Toader, V. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.06.013 · Cited by 171
Belder, A. J. D., MacAllister, R., Radomski, M. W., Moncada, S., & Vallance, P. J. T. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.5.691 · Cited by 170
Nakamura, Y., Moss, A. J., Brown, M. W., Kinoshita, M., & Kawai, C. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70163-8 · Cited by 165
Does Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?
Kleschyov, A. L., Oelze, M., Daiber, A., Huang, Y., Mollnau, H., Schulz, E., Sydow, K., Fichtlscherer, B., Mülsch, A., & Münzel, T. (2003) · Circulation Research · doi:10.1161/01.res.0000100067.62876.50 · Cited by 165
The Reaction of Nitrogen(II) Oxide with Diethylamine
Drago, R. S., & Paulik, F. E. (1960) · Journal of the American Chemical Society · doi:10.1021/ja01486a021 · Cited by 163
The therapeutic potential of NO‐NSAIDs
Wallace, J. L., & Soldato, P. D. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00125.x · Cited by 162
Shami, P. J., Saavedra, J. E., Wang, L. Y., Bonifant, C. L., Diwan, B. A., Singh, S. V., Gu, Y., Fox, S. D., Buzard, G. S., Citro, M. L., et al. (2003) · PubMed · Cited by 162
Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
Herman, A. G., & Moncada, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi333 · Cited by 156
Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis
Taylor, E., Megson, I. L., Haslett, C., & Rossi, A. G. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401152 · Cited by 154
Self-citationAnnich, G. M., Meinhardt, J. P., Mowery, K. A., Ashton, B. A., Merz, S. I., Hirschl, R. B., Meyerhoff, M. E., & Bartlett, R. H. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00001 · Cited by 152
NO-aspirins: a class of new anti-inflammatory and antithrombotic agents
Soldato, P. D., Sorrentino, R., & Pinto, A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01353-x · Cited by 148
Pluta, R. M., Oldfield, E. H., & Boock, R. J. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.87.5.0746 · Cited by 145
Potential cardioprotective actions of no-releasing aspirin
Wallace, J. L., Ignarro, L. J., & Fiorucci, S. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd794 · Cited by 144
Nitroglycerin Tolerance in Human Vessels
Sage, P. R., de la Lande, I. S., Stafford, I., Bennett, C. L., Phillipov, G., Stubberfield, J., & Horowitz, J. D. (2000) · Circulation · doi:10.1161/01.cir.102.23.2810 · Cited by 143
Localizing Antithrombotic and Vasodilatory Activity with a Novel, Ultrafast Nitric Oxide Donor
Saavedra, J. E., Southan, G. J., Davies, K. M., Lundell, A., Markou, C., Hanson, S. R., Adrie, C., Hurford, W. E., Zapol, W. M., & Keefer, L. K. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960616s · Cited by 143
Gori, T., & Parker, J. D. (2002) · Circulation · doi:10.1161/01.cir.0000036743.07406.53 · Cited by 143
Recent chemical studies of sodium nitroprusside relevant to its hypotensive action
Butler, A. R., & Glidewell, C. (1987) · Chemical Society Reviews · doi:10.1039/cs9871600361 · Cited by 142
Nitric Oxide/Nucleophile Complexes: A Unique Class of Nitric Oxide-Based Vasodilators
Morley, D. L., & Keefer, L. K. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199300221-00003 · Cited by 142
Saavedra, J. E., Shami, P. J., Wang, L. Y., Davies, K. M., Booth, M. N., Citro, M. L., & Keefer, L. K. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9903850 · Cited by 132
Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia.
Drexler, H., & Zeiher, A. M. (1991) · Hypertension · doi:10.1161/01.hyp.18.4_suppl.ii90 · Cited by 131
Sodium Nitroprusside: Mechanism of NO Release Mediated by Sulfhydryl-Containing Molecules
Grossi, L., & D'Angelo, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049857n · Cited by 129
Effect of Superoxide Dismutase on the Stability ofS-Nitrosothiols
Jourd'heuil, D., Laroux, F. S., Miles, A. M., Wink, D. A., & Grisham, M. B. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1010 · Cited by 123
Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators.
Morley, D. L., & Keefer, L. K. (1993) · PubMed · Cited by 122
Schoenfisch, M. H., Mowery, K. A., Rader, M. V., Baliga, N., Wahr, J. A., & Meyerhoff, M. E. (2000) · Analytical Chemistry · doi:10.1021/ac991370c · Cited by 122
Seabra, A. B., Fitzpatrick, A., Paul, J., de Oliveira, M. G., & Weller, R. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06213.x · Cited by 115
Antiinflammatory, Gastrosparing, and Antiplatelet Properties of New NO-Donor Esters of Aspirin
Cena, C., Lolli, M. L., Lazzarato, L., Guaita, E., Morini, G., Coruzzi, G., McElroy, S. P., Megson, I. L., Fruttero, R., & Gasco, A. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020969t · Cited by 112
Self-citationVelázquez, C. A., Rao, P. P. N., & Knaus, E. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050211k · Cited by 111
Bak, A., McKnight, W., Li, P., Soldato, P. D., Calignano, A., Cirino, G., & Wallace, J. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00191-x · Cited by 110
Endothelial nitric oxide synthase modulates gastric ulcer healing in rats
Ma, L., & Wallace, J. L. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.279.2.g341 · Cited by 110
Nitric Oxide‐Releasing Drugs: A Novel Class of Effective and Safe Therapeutic Agents
Burgaud, J., Ongini, E., & Soldato, P. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04080.x · Cited by 109
Sogo, N., Magid, K. S., Shaw, C. A., Webb, D. J., & Megson, I. L. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3976 · Cited by 107
Self-citationAfter 130 years, the molecular mechanism of action of nitroglycerin is revealed
Ignarro, L. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132271799 · Cited by 105
Stilo, A. D., Visentin, S., Cena, C., Gasco, A. M., Ermondi, G., & Gasco, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9803267 · Cited by 102
The Puzzle of Nitrate Tolerance: Pieces Smaller Than We Thought?
Gori, T., & Parker, J. D. (2002) · Circulation · doi:10.1161/01.cir.0000036742.52907.91 · Cited by 101
Fiorucci, S., Santucci, L., Cirino, G., Mencarelli, A., Familiari, L., Soldato, P. D., & Morelli, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5245 · Cited by 100
Ongini, E., Impagnatiello, F., Bonazzi, A., Guzzetta, M., Govoni, M., Monopoli, A., Soldato, P. D., & Ignarro, L. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401996101 · Cited by 100
Nitric oxide donor drugs: current status and future trends
Webb, D. J., & Megson, I. L. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.5.587 · Cited by 99
Self-citationKollau, A., HOFER, A., Russwurm, M., Koesling, D., Keung, W. M., Schmidt, K., Brünner, F., & Mayer, B. (2005) · Biochemical Journal · doi:10.1042/bj20041354 · Cited by 96
Enhanced anti-inflammatory effects of a nitric oxide–releasing derivative of mesalamine in rats
Wallace, J. L., Vergnolle, N., Muscará, M. N., Asfaha, S., Chapman, K., McKnight, W., Soldato, P. D., Morelli, A., & Fiorucci, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70448-8 · Cited by 96
In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016
Wallace, J. L., Muscará, M. N., McKnight, W., Dicay, M. S., Soldato, P. D., & Cirino, G. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(98)00134-0 · Cited by 93
Frost, M. C., & Meyerhoff, M. E. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30275 · Cited by 92
Haemoglobin: NO transporter, NO inactivator or NOne of the above?
Hobbs, A. J., Gladwin, M. T., Patel, R. P., Williams, D. L. H., & Butler, A. R. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02067-9 · Cited by 88
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice
Claudio Napoli, A., Cirino, G., Soldato, P. D., Sorrentino, R., Sica, V., Condorelli, M., Pinto, A., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041602898 · Cited by 84
Lees, C., Langford, E. J., BROWN, A., DeBelder, A., PICKLES, A., MARTIN, J. F., & Campbell, S. C. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(96)00070-1 · Cited by 83
Bandarage, U. K., Chen, L., Fang, X., Garvey, D. S., Glavin, A., Janero, D. R., Letts, L. G., Mercer, G. J., Saha, J. K., Schroeder, J. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000178w · Cited by 81
S -Nitrosoglutathione Reduces the Rate of Embolization in Humans
Molloy, J., Martin, J. F., Baskerville, P., Fraser, S. C. A., & Markus, H. S. (1998) · Circulation · doi:10.1161/01.cir.98.14.1372 · Cited by 80
l -Arginine and S -Nitrosoglutathione Reduce Embolization in Humans
Káposzta, Z., Baskerville, P., Madge, D. J., Fraser, S. C. A., Martin, J. F., & Markus, H. S. (2001) · Circulation · doi:10.1161/01.cir.103.19.2371 · Cited by 80
Morley, D. L., Maragos, C. M., Zhang, X., Boignon, M., Wink, D. A., & Keefer, L. K. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199304000-00023 · Cited by 78
Megson, I. L. (2000) · Drugs of the Future · doi:10.1358/dof.2000.025.07.858691 · Cited by 78
Self-citationSynthesis and cytotoxicity of 5-fluorouracil/diazeniumdiolate conjugates
Cai, T., Tang, X., Nagorski, J., Brauschweiger, P. G., & Wang, P. G. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.003 · Cited by 75
Efficacy and age-related effects of nitric oxide-releasing aspirin on experimental restenosis
Claudio Napoli, A., Aldini, G., Wallace, J. L., de Nigris, F., Maffei, R., Abete, P., Bonaduce, D., Condorelli, G., Rengo, F., Sica, V., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022639399 · Cited by 75
Bennett, B. M., Leitman, D. C., Schröder, H., Kawamoto, J. H., Nakatsu, K., & Murad, F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21364-7 · Cited by 75
Long-Term Nitrate Treatment Increases Cardiac Events in Patients With Healed Myocardial Infarction
Ishikawa, K., Kanamasa, K., Ogawa, I., Takenaka, T., Naito, T., Kamata, N., Yamamoto, T., Nakai, S., Hama, J., Oyaizu, M., et al. (1996) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.60.779 · Cited by 74
Bath, P. M. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315350 · Cited by 74
Kaul, S., Cercek, B., Rengstrom, J., Xu, X.-P., Molloy, M. D., Dimayuga, P. C., Parikh, A. K., Fishbein, M. C., Nilsson, J. Å., Rajavashisth, T. B., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00543-4 · Cited by 72
Chaux, A., Ruan, X. M., Fishbein, M. C., Ouyang, Y., Kaul, S., Pass, J. A., & Matloff, J. M. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70325-3 · Cited by 71
Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance
DiFabio, J. M., Ji, Y., Vasiliou, V., Thatcher, G. R. J., & Bennett, B. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1109 · Cited by 71
Krieger, M. H., Santos, K. F., Shishido, S. M., Wanschel, A. C. B. A., Estrela, H. F. G., dos Santos, L., de Oliveira, M. G., Franchini, K. G., Spadari-Bratfisch, R. C., & Laurindo, F. R. M. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.07.011 · Cited by 68
Crane, M. S., Rossi, A. G., & Megson, I. L. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706110 · Cited by 67
Self-citationPrevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin
Momi, S., Emerson, M., Paul, W., Leone, M., Mezzasoma, A. M., Soldato, P. D., Page, C. P., & Gresele, P. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00223-5 · Cited by 65
Lechi, C., Andrioli, G., Gaino, S., Tommasoli, R., Zuliani, V., Ortolani, R., Degan, M., Benoni, G., Bellavite, P., Lechi, A., et al. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650662 · Cited by 63
Glycosylated diazeniumdiolates: a novel class of enzyme-activated nitric oxide donors
Wu, X., Tang, X., Xian, M., & Wang, P. G. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)00614-1 · Cited by 62
The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces
Maalej, N. M., Albrecht, R. M., Loscalzo, J., & Folts, J. D. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00687-1 · Cited by 62
Diodati, J. G., Quyyumi, A. A., Hussain, N., & Keefer, L. K. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649644 · Cited by 61
Saavedra, J. E., Booth, M. N., Hrabie, J. A., Davies, K. M., & Keefer, L. K. (1999) · The Journal of Organic Chemistry · doi:10.1021/jo9901539 · Cited by 60
Mechanism of action of novel NO‐releasing furoxan derivatives of aspirin in human platelets
Turnbull, C. M., Cena, C., Fruttero, R., Gasco, A., Rossi, A. G., & Megson, I. L. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706743 · Cited by 60
Self-citationKatsumi, H., Nishikawa, M., Yamashita, F., & Hashida, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087429 · Cited by 59
Role of superoxide dismutase in in vivo and in vitro nitrate tolerance
Münzel, T. F., Hink, U., Yigit, H., Macharzina, R. R., Harrison, D. G., & Mülsch, A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702622 · Cited by 57
Preparation and Properties of S-Nitroso- l -Cysteine Ethyl Ester, an Intracellular Nitrosating Agent
Clancy, R. M., Cederbaum, A. I., & Stoyanovsky, D. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000463f · Cited by 57
Yamamoto, T., & Bing, R. J. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1111/j.1525-1373.2000.22525.x · Cited by 57
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Loscalzo, J., Smick, D., Andon, N., & Cooke, J. P. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23489-9 · Cited by 55
Yurtseven, N., Karaca, P. E., Kaplan, M., Özkul, V., TUYGUN, A. K., Aksoy, T., Canik, S., & Kopman, E. A. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00017 · Cited by 54
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties
Boschi, D., Tron, G. C., Lazzarato, L., Chegaev, K. Y., Cena, C., Stilo, A. D., Giorgis, M., Bertinaria, M., Fruttero, R., & Gasco, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0510530 · Cited by 54
Zhang, J., Chen, Z., Cobb, F. R., & Stamler, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000138105.17864.6b · Cited by 52
Fujihara, C. K., Malheiros, D. M. A. C., Donato, J. L., Poli, A., Nucci, G. D., & Zatz, R. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.3.f573 · Cited by 52
Are Drug-Eluting Stents Cost-Effective?
Ryan, J. W., & Cohen, D. J. (2006) · Circulation · doi:10.1161/circulationaha.105.546010 · Cited by 51
Simpson, D., & Wellington, K. (2004) · Drugs · doi:10.2165/00003495-200464170-00012 · Cited by 51
Megson, I. L., Greig, I. R., Gray, G. A., Webb, D. J., & BUTLER, A. R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701557 · Cited by 49
Self-citationMegson, I. L., Morton, S., Greig, I. R., Mazzei, F. A., Field, R. A., Butler, A. R., Caron, G., Gasco, A., Fruttero, R., & Webb, D. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702346 · Cited by 49
Self-citationNitric Oxide Donors: A Continuing Opportunity in Drug Design
Hanson, S. R., Hutsell, T. C., Keefer, L. K., Mooradian, D. L., & Smith, D. J. (1995) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)61099-6 · Cited by 47 · cited 2×
“MAHMA/NOeluting stents also reduce platelet adhesion to artificial grafts (Hanson et al., 1995).”
BackgroundSalas, E., Langford, E. J., Marrinan, M. T., Martin, J. F., Moncada, S., & de Belder, A. (1998) · Heart · doi:10.1136/hrt.80.2.146 · Cited by 47
Crane, M. S., Ollosson, R., Moore, K. P., Rossi, A. G., & Megson, I. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208608200 · Cited by 46
Self-citationMatsuo, H. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00202-1 · Cited by 46
Miller, M. R., Roseberry, M. J., Mazzei, F. A., Butler, A. R., Webb, D. J., & Megson, I. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00777-9 · Cited by 45
Self-citationNeuroprotective properties of nitric oxide and -nitrosoglutathione
Rauhala, P. V., ANDOH, T., & Chiueh, C. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.02.028 · Cited by 45
Wu, W., Hao, J., Ongini, E., Impagnatiello, F., Presotto, C., Wiesenfeld‐Hallin, Z., & Xu, X. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705596 · Cited by 44
Fruttero, R., Boschi, D., Stilo, A. D., & Gasco, A. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00025a012 · Cited by 42
NO-aspirin: mechanism of action and gastrointestinal safety
Fiorucci, S., & Soldato, P. D. (2003) · Digestive and Liver Disease · doi:10.1016/s1590-8658(03)00047-1 · Cited by 42
Switching off Embolization From Symptomatic Carotid Plaque Using S -Nitrosoglutathione
Káposzta, Z., Martin, J. F., & Markus, H. S. (2002) · Circulation · doi:10.1161/01.cir.0000012347.47001.97 · Cited by 41
Goyal, P., Kiran, U., Chauhan, S., Juneja, R., & Choudhary, M. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/ael112 · Cited by 41
Synthesis of peptide-diazeniumdiolate conjugates: towards enzyme activated antitumor agents
Tang, X., Xian, M., Trikha, M., Honn, K. V., & Wang, P. G. (2001) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)00263-5 · Cited by 41
Systemic effects of S‐nitroso‐glutathione in the human following intravenous infusion.
Ramsay, B., Radomski, M. W., de Belder, A., Martin, J., & López-Jaramillo, P. A. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04545.x · Cited by 40
Bertinaria, M., Galli, U., Sorba, G., Fruttero, R., Gasco, A., Brenciaglia, M. I., Scaltrito, M. M., & Dubini, F. (2003) · Drug Development Research · doi:10.1002/ddr.10284 · Cited by 39
Molecular targets of nitric-oxide-donating aspirin in cancer
Kashfi, K., & Rigas, B. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330701 · Cited by 39
Brilli, R. J., Krafte‐Jacobs, B., Smith, D. J. B., Roselle, D. C., Passerini, D., Vromen, A., Moore, L., Szabó, C., & Salzman, A. L. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.1968 · Cited by 39
Vanderford, P. A., Wong, J. Y., Chang, R., Keefer, L. K., Soifer, S. J., & Fineman, J. R. (1994) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199401000-00016 · Cited by 38
Chen, C., Hanson, S. R., Keefer, L. K., Saavedra, J. E., Davies, K. M., Hutsell, T. C., Hughes, J., Ku, D. N., & Lumsden, A. B. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1996.4915 · Cited by 36
Fiorucci, S., Mencarelli, A., Meneguzzi, A., Lechi, A., Renga, B., Soldato, P. D., Morelli, A., & Minuz, P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.079 · Cited by 36
Gourine, A. V., Bulhak, A., Gonon, A. T., Pernow, J., & Sjöquist, P.-O. B. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00114-3 · Cited by 36
Eisenberg, M. J. (2006) · Circulation · doi:10.1161/circulationaha.106.646190 · Cited by 36
Franceschi, L. D., Malpeli, G., Scarpa, A., Janin, A., Muchitsch, E. M., Roncada, P., Lebœuf, C., Corrocher, R., Beuzard, Y., & Brugnara, C. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00462.2005 · Cited by 33
Rajaratnam, R., Brieger, D. B., Hawkins, R., & Freedman, B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00025-9 · Cited by 32
Hanspal, I. S., Magid, K. S., Webb, D. J., & Megson, I. L. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0412 · Cited by 32
Self-citationA NITRIC OXIDE DONOR (SPERMINE‐NONOATE) PREVENTS THE FORMATION OF NEOINTIMA IN RABBIT CAROTID ARTERY
Yin, Z., & Dusting, G. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01218.x · Cited by 31
Haga, S. B., & Ginsburg, G. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.017 · Cited by 30
Jayachandran, M., Hayashi, T., Sumi, D., Thakur, N. K., Kano, H., Ignarro, L. J., & Iguchi, A. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4177 · Cited by 30
Studies on Agents with Mixed NO-Dependent Vasodilating and β-Blocking Activities
Boschi, D., Stilo, A. D., Cena, C., Lolli, M. L., Fruttero, R., & Gasco, A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136030849 · Cited by 30
Nitric Oxide Decreases Coagulation Protein Function in Rabbits as Assessed by Thromboelastography
Nielsen, V. G. (2001) · Anesthesia & Analgesia · doi:10.1213/00000539-200102000-00006 · Cited by 30
Delyani, J. A., Nossuli, T. O., Scalia, R. G., Thomas, G., Garvey, D. S., & Lefer, A. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21274-5 · Cited by 29
Vilahur, G., Baldellou, M. I., Segalés, E., Salas, E., & Badimon, L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.034 · Cited by 29
Nitrosoglutathione triggers collagen deposition in cutaneous wound repair
Achuth, H. N., Moochhala, S., Mahendran, R., & Tan, W. T. L. (2005) · Wound Repair and Regeneration · doi:10.1111/j.1067-1927.2005.130405.x · Cited by 25
[3-(1H-Imidazol-4-yl)propyl]guanidines containing furoxan moieties
Bertinaria, M., Stilo, A. D., Tosco, P., Sorba, G., Poli, E., Pozzoli, C., Coruzzi, G., Fruttero, R., & Gasco, A. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00651-x · Cited by 24
Schulz, G., & Stechmiller, J. K. (2006) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734606286633 · Cited by 24
A Glycosylated Nitric Oxide Donor, β‐Gal‐NONOate, and its Site‐specific Antitumor Activity
Chen, C., Shi, Y., Li, S., Qi, Q., Gu, L., Song, J., & Wang, P. G. (2006) · Archiv der Pharmazie · doi:10.1002/ardp.200500262 · Cited by 23
de la Lande, I. S., Stepien, J. M., Philpott, A. C., Hughes, P. A., Stafford, I., & Horowitz, J. D. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.010 · Cited by 22
A New Furoxan NO‐Donor Rabeprazole Derivative and Related Compounds
Sorba, G., Galli, U., Cena, C., Fruttero, R., Gasco, A., Morini, G., Adami, M., Coruzzi, G., Brenciaglia, M. I., & Dubini, F. (2003) · ChemBioChem · doi:10.1002/cbic.200300617 · Cited by 21
NO–Steroids: Potent Anti-inflammatory Drugs with Bronchodilating Activity in Vitro
Tallet, D., Soldato, P. D., Oudart, N., & Burgaud, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6192 · Cited by 21
Saavedra, J. E., Mooradian, D. L., Mowery, K. A., Schoenfisch, M. H., Citro, M. L., Davies, K. M., Meyerhoff, M. E., & Keefer, L. K. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00086-x · Cited by 21
Therapeutic effects of nitric oxide-aspirin hybrid drugs
Turnbull, C. M., Rossi, A. G., & Megson, I. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.6.911 · Cited by 18
Self-citationChen, C., Shi, Y., Song, J., Qi, Q., Gu, L., & Wang, P. G. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1239 · Cited by 18
Miller, M. R., Okubo, K., Roseberry, M. J., Webb, D. J., & Megson, I. L. (2004) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200403000-00016 · Cited by 18
Self-citationEffects of Nicorandil on Endogenous Fibrinolytic Capacity in Patients With Coronary Artery Disease
Sakamoto, T., Kaikita, K., Miyamoto, S., Kojima, S., Sugiyama, S., Yoshimura, M., & Ogawa, H. (2004) · Circulation Journal · doi:10.1253/circj.68.232 · Cited by 18
Jacobs, B. R., Smith, D. J. B., Zingarelli, B., Passerini, D. J., Ballard, E. T., & Brilli, R. J. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0292 · Cited by 18
Effect of a nitric oxide releasing derivative of paracetamol in a rat model of endotoxaemia
Marshall, M. J., Keeble, J. E., & Moore, P. K. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706855 · Cited by 17
Miller, M. R., Hanspal, I. S., Hadoke, P. W. F., Newby, D. E., Rossi, A. G., Webb, D. J., & Megson, I. L. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00779-4 · Cited by 14
Self-citationAquart, D. V., & Dasgupta, T. P. (2003) · Biophysical Chemistry · doi:10.1016/j.bpc.2003.08.011 · Cited by 14
Sogo, N., Wilkinson, I. B., MacCallum, H., Khan, S. Q., Strachan, F. E., Newby, D. E., Megson, I. L., & Webb, D. J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.107049 · Cited by 14
Self-citationTherapeutic Importance of Nitrovasodilators
Kojda, G. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57077-3_16 · Cited by 12
Young, D. V., Cochran, E. D., DHAWAN, V. M., Earl, R. A., Ellis, J. L., Garvey, D. S., Janero, D. R., Khanapure, S. P., Letts, L. G., Melim, T. L., et al. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.08.004 · Cited by 11
Nitric Oxide Delivery in Stagnant Systems via Nitric Oxide Donors: A Mathematical Model
Kavdia, M., & Lewis, R. S. (2002) · Chemical Research in Toxicology · doi:10.1021/tx025528r · Cited by 10
Lam, C., Caterina, P., Filion, P., Ilett, K. F., & van Heerden, P. V. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00193-5 · Cited by 10
Burke, S. G., Wainwright, C. L., Vojnovic, I., Warner, T. D., Watson, D. G., & Furman, B. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096339 · Cited by 9
Quintana, A., Rodriguez, J. V., Scandizzi, A. L., et al. (2001) · PubMed · Cited by 9
S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery
Zhang, C. L., de la Lande, I. S., Stafford, I., & Horowitz, J. D. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90176-7 · Cited by 6
Megson, I. L. (2002) · Drugs of the Future · doi:10.1358/dof.2002.027.08.688457 · Cited by 3 · cited 2×
“We hypothesized that these novel compounds are retained in the lipophilic areas of the subendothelium where they slowly release NO over a prolonged period (Megson, 2002).”
BackgroundSelf-citationBiDil (Isosorbide Dinitrate and Hydralazine Hydrochloride)
Sica, D. A. (2006) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2006.04960.x · Cited by 1
Cited by
Plasma medicine: an introductory review
Kong, M. G., Kroesen, G., Morfill, G., Nosenko, T., Shimizu, T., van Dijk, J., & Zimmermann, J. L. (2009) · New Journal of Physics · doi:10.1088/1367-2630/11/11/115012 · Cited by 1,601
Graves, D. B. (2012) · Journal of Physics D: Applied Physics · doi:10.1088/0022-3727/45/26/263001 · Cited by 1,518
BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications
McKinlay, A. C., Morris, R. E., Horcajada, P., Férey, G., Gref, R., Couvreur, P., & Serre, C. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000048 · Cited by 1,256
Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,127
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Metadata
- Authors
- Miller, M. R., & Megson, I. L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-06
- Volume
- 151
- Issue
- 3
- Pages
- 305-321
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1479760463
- Cited by
- 628
- References
- 199
- FWCI
- 16.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.